The complex journey from R&D to vaccination

The next major challenge – to produce, distribute and administer billions of COVID-19 vaccines worldwide – is already under way. But the sheer complexity of the journey from R&D to a jab in the arm, involving intricate supply chains across multiple countries, is without precedent.

Read more in the policy paper Using trade to fight COVID-19: Manufacturing and distributing vaccines

See also: The race to vaccinate